Published in
Taylor and Francis Group, Molecular && Cellular Oncology, 2(7), p. 1715766, 2020
DOI: 10.1080/23723556.2020.1715766
Links
Tools
CD36: a key mediator of resistance to HER2 inhibitors in breast cancer
This paper was not found in any repository, but could be made available legally by the author.
Full text: Unavailable
Published version:
archiving forbidden
Data provided by 